These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification. Genest DR; Dorfman DM; Castrillon DH J Reprod Med; 2002 May; 47(5):342-6. PubMed ID: 12063872 [TBL] [Abstract][Full Text] [Related]
51. Diagnostic utility of p57 immunohistochemistry and DNA ploidy analysis by fluorescence in situ hybridisation in hydatidiform moles. Wong YP; Chia WK; Selimin A; Chia PY; Mustangin M; Shuib S; Khong TY; Tan GC Malays J Pathol; 2021 Dec; 43(3):341-351. PubMed ID: 34958055 [TBL] [Abstract][Full Text] [Related]
52. Parental contribution to trisomy in heterozygous androgenetic complete moles. Usui H; Sato A; Shozu M Sci Rep; 2020 Oct; 10(1):17137. PubMed ID: 33051545 [TBL] [Abstract][Full Text] [Related]
53. When to Consult a Geneticist Specialising in Gestational Trophoblastic Disease. McMahon L; Maher GJ; Joyce C; Niemann I; Fisher R; Sunde L Gynecol Obstet Invest; 2024; 89(3):198-213. PubMed ID: 37245506 [TBL] [Abstract][Full Text] [Related]
54. DNA analysis of partial hydatidiform mole revealing triandric monogynic tetraploidy. Gergely L; Korbeľ M; Repiská V; Danihel Ľ; Hutník J; McCullough L; Priščáková P Ceska Gynekol; 2023; 88(6):446-449. PubMed ID: 38171918 [TBL] [Abstract][Full Text] [Related]
55. Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease. Kaneki E; Kobayashi H; Hirakawa T; Matsuda T; Kato H; Wake N Cancer Sci; 2010 Jul; 101(7):1717-21. PubMed ID: 20518791 [TBL] [Abstract][Full Text] [Related]
56. P57 Awosusi BL; Ajani MA; Adegoke OO; Salami AA; Okolo CA Niger Postgrad Med J; 2020; 27(4):331-335. PubMed ID: 33154286 [TBL] [Abstract][Full Text] [Related]
57. Human epidermal growth factor receptor 2 fluorescence in situ hybridization and P57KIP2 immunohistochemistry using tissue microarray: Improving histopathological subtyping of hydatidiform mole. López CL; Figueira Gouvêa AL; Rodrigues FR; Braga A; Valente Machado MD; Lopes VS Placenta; 2020 Sep; 99():166-172. PubMed ID: 32810764 [TBL] [Abstract][Full Text] [Related]
58. p57 in Hydatidiform Moles: Evaluation of Antibodies and Expression in Various Cell Types. Lund H; Nielsen S; Grove A; Vyberg M; Sunde L Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):694-701. PubMed ID: 31567274 [TBL] [Abstract][Full Text] [Related]
59. Recurrent pregnancy loss in a woman with NLRP7 mutation: not all molar pregnancies can be easily classified as either "partial" or "complete" hydatidiform moles. Brown L; Mount S; Reddy R; Slim R; Wong C; Jobanputra V; Clifford P; Merrill L; Brown S Int J Gynecol Pathol; 2013 Jul; 32(4):399-405. PubMed ID: 23722513 [TBL] [Abstract][Full Text] [Related]
60. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. Jun SY; Ro JY; Kim KR Histopathology; 2003 Jul; 43(1):17-25. PubMed ID: 12823708 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]